TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.

Purpose: We previously reported a dose-finding and phase II trial of the TI-CE regimen (paclitaxel [T] plus ifosfamide [I] followed by high-dose carboplatin [C] plus etoposide [E] with stem-cell support) in germ cell tumor (GCT) patients predicted to have a poor prognosis with conventional-dose salv...

Full description

Bibliographic Details

Published in:	Journal of Clinical Oncology Vol. 28; no. 10; pp. 1706 - 1714
Main Authors:	Feldman DR, Sheinfeld J, Bajorin DF, Fischer P, Turkula S, Ishill N, Patil S, Bains M, Reich LM, Bosl GJ, Motzer RJ, Feldman, Darren R, Sheinfeld, Joel, Bajorin, Dean F, Fischer, Patricia, Turkula, Stefan, Ishill, Nicole, Patil, Sujata, Bains, Manjit, Reich, Lilian M
Format:	research Journal Article
Published:	American Society of Clinical Oncology 4/1/2010
Online Access:	View this record in EBSCOhost